Insider · CIK 0001829051
5AM Partners VI, LLC
Files at CAMP (Camp4 Therapeutics Corp). First filing Oct 15, 2024, latest Sep 15, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CAMP: Camp4 Therapeutics Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 63Notable | Camp4 Therapeutics Corp | $4.5M 2,941,176 shares | - | +106% from low-76% from high | |
| 57Moderate | Camp4 Therapeutics Corp | $10.0M 909,090 shares | +53% | +10% from low0% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 11, 2025 | CAMP Camp4 Therapeutics Corp | POpen-market purchase Common Stockindirect: By 5AM Ventures VII, L.P. | +2,941,176 | $1.53 | $4.5M | 2,941,176 | Sep 15, 2025 |
| Oct 15, 2024 | CAMP Camp4 Therapeutics Corp | CConversion Common Stockindirect: By 5AM Ventures VI, L.P. | +1,716,055 | - | - | 1,716,055 | Oct 15, 2024 |
| Oct 15, 2024 | CAMP Camp4 Therapeutics Corp | CConversion Common Stockindirect: By 5AM Opportunities II, L.P. | +302,770 | - | - | 302,770 | Oct 15, 2024 |
| Oct 15, 2024 | CAMP Camp4 Therapeutics Corp | POpen-market purchase Common Stockindirect: By 5AM Ventures VI, L.P. | +909,090 | $11.00 | $10.0M | 2,625,145 | Oct 15, 2024 |
| Oct 15, 2024 | CAMP Camp4 Therapeutics Corp | CConversion Series A Prime Preferred Stockderivativeindirect: By 5AM Ventures VI, L.P. | -15,002,166 | - | - | 0 | Oct 15, 2024 |
| Oct 15, 2024 | CAMP Camp4 Therapeutics Corp | CConversion Series B Preferred Stockderivativeindirect: By 5AM Ventures VI, L.P. | -4,244,770 | - | - | 0 | Oct 15, 2024 |
| Oct 15, 2024 | CAMP Camp4 Therapeutics Corp | CConversion Series B Preferred Stockderivativeindirect: By 5AM Opportunities II, L.P. | -3,395,816 | - | - | 0 | Oct 15, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.